Virus Purification via Sequential Chromatography
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for purifying infectious poliovirus, such as one-step hydroxyapatite chromatography, fail to effectively remove contaminants with physical characteristics similar to the virus, leading to denaturation and low production efficiency, especially in the case of the Sabin type 2 vaccine strain.
Innovation Solution
A sequential two-step chromatographic purification method using a ceramic fluoroapatite column for the first step and a ceramic hydroxyapatite column for the second step, employing pH gradient elution and salt concentration gradient elution respectively, to remove protein contaminants and double-stranded DNA, thereby preventing virus denaturation and achieving high purity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If one-step hydroxyapatite chromatography is used for virus purification, then the process is simple and fast, but contaminants with similar physical characteristics cannot be effectively removed and virus denaturation occurs
Solution Approach 1:
The single-step purification process is divided into three sequential chromatography steps using different resins (Q Sepharose, Hydroxyapatite, and Fluoroapatite), where each step targets specific contaminants. This segmentation allows removal of different contaminant types at optimized conditions, achieving both high purity and maintained productivity.
Solution Approach 2:
The invention employs a combination of three different chromatography resins with distinct mechanisms (ion exchange, hydroxyapatite binding, and fluoroapatite binding) to create a composite purification system. Each resin contributes unique separation capabilities, enabling comprehensive contaminant removal while preserving virus infectivity.
2Manufacturing precision
If ultracentrifugation is used for virus purification, then density separation can be achieved, but the process is time-consuming and has low scalability
Solution Approach 1:
The invention replaces the mechanical ultracentrifugation system with a chromatography-based liquid phase separation system. This substitution eliminates the need for high-speed centrifuges and density gradients, enabling easier scale-up while maintaining separation precision through controlled elution conditions.
Solution Approach 2:
The purification process utilizes changes in chemical parameters (pH, ionic strength, specific ion concentrations) to achieve separation instead of relying on physical density differences. This allows for precise control of separation conditions and easier scaling by simply adjusting flow rates and buffer compositions.
3Reliability
If standardized one-step purification is used, then the process is reproducible, but it causes virus denaturation and loses infectivity
Solution Approach 1:
The invention employs dynamic elution conditions with sequential changes in pH and ionic strength across three chromatography steps. This dynamic approach allows gentle elution of the virus at optimized conditions for each step, preventing denaturation while maintaining reproducible results through standardized protocols.
Solution Approach 2:
The three chromatography resins act as intermediaries that selectively bind and remove contaminants while allowing the virus to pass through or be gently eluted. Each resin mediates the removal of specific contaminant types, protecting the virus from direct exposure to harsh purification conditions that would cause denaturation.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method achieves removal rates of 99.95% or more for proteins and 99.99% or more for double-stranded DNA, ensuring high reproducibility and scalability, while maintaining the infectivity of the virus, thus addressing the limitations of existing techniques.
Implementation Method 1
In the first step, we removed protein contaminants from the Sabin type 2 virus fraction by pH gradient elution on a ceramic fluoroapatite column
Implementation Method 2
In the second step, we removed double-stranded DNA derived from host cells by diluting the virus fraction, directly loading it on a CHAp column, and purifying it using a phosphate gradient with 1 M sodium chloride
Implementation Method 3
Scanning electron microscopy analysis confirmed that the virus particles were bound to and released from the surface of the hydroxyapatite via the chromatographic processes, clearly indicating the phosphate-dependent adsorption/desorption mechanism of hydroxyapatite
Data Source
AI summary
[Problems] The present invention provides a purification method capable of more effectively removing the contaminants with physical characteristics similar to the virus from the composition containing the virus, while preventing the denaturation of the virus, than conventional methods.[Means to solve problems] A purification method for removing a contaminant from a composition containing a virus particle and the contaminant, the purification method comprising: a preparation step of preparing the composition containing a virus particle and a contaminant; a first adsorption step of adsorbing the virus particle on a first adsorbent composed of a calcium phosphate compound by contacting the composition with the first adsorbent; a first elution step of eluting the virus particle from the first adsorbent to obtain a first eluate; a second adsorption step of adsorbing the virus particle on a second adsorbent composed of a calcium phosphate compound by contacting the first eluate with the second adsorbent; and a second elution step of eluting the virus particle from the second adsorbent to obtain a second eluate; one of the first elution step and the second elution step comprising pH gradient elution, and the other comprising salt concentration gradient elution.